Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by MONTRONE, F.
Right arrow Articles by PONTIROLP, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MONTRONE, F.
Right arrow Articles by PONTIROLP, A. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1979 British Society for Rheumatology


research-article

A DOUBLE-BLIND CROSS-OVER EVALUATION OF KETOPROFEN (ORUDIS) AND IBUPROFEN IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS

F. MONTRONE1,, M. FUMAGALLP1, P. PELLEGRINI2, G. RATTI3, G. SALA4, C. LIVERTA5, C. POLLINI5 and A. E. PONTIROLP5

1Servizio di Reumatologia, Ospedale Luigi Sacco 20157 Milan
2Reparto di Reumatologia, Ospedale S. Anna Ferrara
3Divisione Medica 1, Ospedale Civile Busto Arsizio
4Divisione B di Medicina, Ospedale di Circolo Varese
5Direzione Medica Farmitalia Milan, Italy

Correspondence to: Requests for reprints to Dr. F. Montrone

In a multi-centre double-blind cross-over trial using the double-placebo technique, 55 patients with rheumatoid arthritis were treated for 10 days for each trial drug with ketoprofen (200 mg/day) and ibuprofen (1200 mg/day). Both drugs induced a clinically and statistically significant improvement of all the symptoms studied, except for pain at night during ibuprofen administration. Ketoprofen displayed a therapeutic efficacy significantly superior to ibuprofen in five out of the eight symptoms studied.

Side-effects were recorded in 10 patients receiving ketoprofen (one patient withdrew because of heartburn) and in nine patients receiving ibuprofen.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.